OCS

Oculis Holding AG OCS

NasdaqSmall CapHealthcare

13F Pro Quality Score

Not in ranked universe

Below size threshold

Below the main board's size threshold of $25M annual revenue or $100M total assets. This company reported $0.0M in revenue and is scored on the micro-cap board instead.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

Net income

$-98.96M

Quarter to Dec 31

Free cash flow

$-66.61M

Quarter to Dec 31

Top Institutional Holders

as of Q2 2026
$323.14M total
Reading the latest SEC filing…

Key Metrics

Net Income

FY 2025
EDGAR

EPS (Diluted)

FY 2025
EDGAR

ROIC

FY 2025
EDGAR

Free Cash Flow

FY 2025
EDGAR

Financial Trends

Revenue & Net Income

13fpro.ai/company/OCS

Earnings Per Share

13fpro.ai/company/OCS

Loading ratio trend…

About Oculis Holding AG (OCS): stock profile, AI score and financials

Oculis Holding AG (OCS) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. OCS is not currently included in 13F Pro's AI-ranked quality universe — below the main board's size threshold of $25m annual revenue or $100m total assets. this company reported $0.0m in revenue and is scored on the micro-cap board instead. Based on the latest XBRL financial filings (FY 2025), Oculis Holding AG reports net income of $-99.0M, free cash flow of $-66.6M. OCS trades on the Nasdaq exchange and files with the SEC under CIK 1953530. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate OCS daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Oculis Holding AG directly from SEC EDGAR.

SEC EDGAR: CIK 1953530 →